Preclinical models in the study of lymph node metastasis.

Area of Science:

• Oncology
• Translational Research
• Preclinical Models

Background:

• Lymph node metastasis (LNM) is a critical prognostic factor in various cancers.
• Understanding tumor behavior and identifying therapeutic targets rely on fundamental research.
• Preclinical experiments bridge basic science discoveries with clinical applications.

Purpose of the Study:

• To review existing in vitro and animal preclinical models for studying tumor lymph node metastasis.
• To identify current challenges and limitations in preclinical cancer metastasis research.
• To provide an outlook on future preclinical models for lymph node metastasis.

Main Methods:

• Summarizing diverse in vivo animal models including mice.
• Detailing methods like carcinogen-induced tumorigenesis, transplantation, genetic engineering, and humanization.
• Including in vitro models and other animal models beyond mice.

Main Results:

• Various preclinical models effectively simulate aspects of tumor lymph node metastasis.
• Carcinogen-induced models mimic tumorigenesis and metastasis.
• Transplantation, genetically engineered, and humanized models offer unique advantages for studying human tumors and immune interactions.

Conclusions:

• Preclinical models are indispensable for advancing the understanding and treatment of lymph node metastasis.
• Addressing current bottlenecks in preclinical research is crucial for future progress.
• Emerging preclinical models hold promise for more accurate cancer metastasis research.